Literature DB >> 21769107

Implications of augmented renal clearance in critically ill patients.

Andrew A Udy1, Jason A Roberts, Jeffrey Lipman.   

Abstract

Critically ill patients can display markedly abnormal physiological parameters compared with those in ward-based or ambulatory settings. As a function of both the underlying inflammatory state and the interventions provided, these patients manifest substantial changes in their cardiovascular and renal function that are not always immediately discernable using standard diagnostic tests. Impaired renal function is well documented among such individuals; however, even patients with normal serum creatinine concentrations might display elevated glomerular filtration rates, a phenomenon we have termed augmented renal clearance (ARC). This finding has important ramifications for the accurate dosing of renally eliminated drugs, given that most pharmaceutical dosing regimens were validated outside the critical care environment. Empirical approaches to dosing are unlikely to achieve therapeutic drug concentrations in patients with ARC, placing them at risk of suboptimal drug exposure and potential treatment failure. With an increasing appreciation of this phenomenon, alternative dosing strategies will need to be investigated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21769107     DOI: 10.1038/nrneph.2011.92

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  55 in total

1.  Is antimicrobial underexposure due to glomerular hyperfiltration a possible cause of increased mortality rate from bacterial infections in critically ill patients?

Authors:  F Pea; M Furlanut; P Viale
Journal:  Anaesth Intensive Care       Date:  2009-03       Impact factor: 1.669

2.  Augmented creatinine clearance in traumatic brain injury.

Authors:  Andrew Udy; Robert Boots; Siva Senthuran; Janine Stuart; Renae Deans; Melissa Lassig-Smith; Jeffrey Lipman
Journal:  Anesth Analg       Date:  2010-11-03       Impact factor: 5.108

Review 3.  Augmented renal clearance: implications for antibacterial dosing in the critically ill.

Authors:  Andrew A Udy; Jason A Roberts; Robert J Boots; David L Paterson; Jeffrey Lipman
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

Review 4.  Drug disposition in cystic fibrosis.

Authors:  E Rey; J M Tréluyer; G Pons
Journal:  Clin Pharmacokinet       Date:  1998-10       Impact factor: 6.447

5.  Accuracy of short-duration creatinine clearance determinations in predicting 24-hour creatinine clearance in critically ill and injured patients.

Authors:  Robert A Cherry; Soumitra R Eachempati; Lynn Hydo; Philip S Barie
Journal:  J Trauma       Date:  2002-08

6.  Vital organ blood flow during hyperdynamic sepsis.

Authors:  David Di Giantomasso; Clive N May; Rinaldo Bellomo
Journal:  Chest       Date:  2003-09       Impact factor: 9.410

7.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

8.  Cefepime versus cefpirome: the importance of creatinine clearance.

Authors:  Jeffrey Lipman; Steven C Wallis; Robert J Boots
Journal:  Anesth Analg       Date:  2003-10       Impact factor: 5.108

9.  Renal function in critically ill postoperative patients: sequential assessment of creatinine osmolar and free water clearance.

Authors:  R Brown; R Babcock; J Talbert; J Gruenberg; C Czurak; M Campbell
Journal:  Crit Care Med       Date:  1980-02       Impact factor: 7.598

10.  Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infection.

Authors:  S Tett; S Moore; J Ray
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

View more
  45 in total

Review 1.  Management of antimicrobial use in the intensive care unit.

Authors:  Francisco Álvarez-Lerma; Santiago Grau
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

Review 2.  [Pharmacokinetics and pharmacodynamics of antibiotic therapy].

Authors:  S Beck; S G Wicha; C Kloft; M G Kees
Journal:  Anaesthesist       Date:  2014-10       Impact factor: 1.041

3.  Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach.

Authors:  Federico Pea; Pierluigi Viale; Piergiorgio Cojutti; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2012-10-08       Impact factor: 5.191

Review 4.  [Strategies to avoid antibiotic resistance].

Authors:  M G Kees
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-01-25       Impact factor: 0.840

5.  Clinical measures for increased creatinine clearances and suboptimal antibiotic dosing.

Authors:  Mathias W Pletz; Jeffrey Lipman
Journal:  Intensive Care Med       Date:  2013-04-20       Impact factor: 17.440

6.  Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.

Authors:  Mohd H Abdul-Aziz; Azrin N Abd Rahman; Mohd-Basri Mat-Nor; Helmi Sulaiman; Steven C Wallis; Jeffrey Lipman; Jason A Roberts; Christine E Staatz
Journal:  Antimicrob Agents Chemother       Date:  2015-10-19       Impact factor: 5.191

7.  Single-Center Pharmacokinetic Study and Simulation of a Low Meropenem Concentration in Brain-Dead Organ Donors.

Authors:  Jae-Myeong Lee; Joo Won Lee; Tae Seok Jeong; Eun Sook Bang; So Hee Kim
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

8.  Antibiotic therapy in hematological neutropenic patients: what is the news?

Authors:  F Pea
Journal:  Leuk Suppl       Date:  2012-08-09

Review 9.  Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?

Authors:  Nilesh Kumta; Jason A Roberts; Jeffrey Lipman; Menino Osbert Cotta
Journal:  Clin Pharmacokinet       Date:  2018-04       Impact factor: 6.447

Review 10.  [Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just "trendy"?]

Authors:  A Brinkmann; A C Röhr; A Köberer; T Fuchs; J Preisenberger; W A Krüger; O R Frey
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-09-13       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.